首页> 外文期刊>BMC Immunology >Investigations of immunogenic, allergenic and adjuvant properties of Cry1Ab protein after intragastric exposure in a food allergy model in mice
【24h】

Investigations of immunogenic, allergenic and adjuvant properties of Cry1Ab protein after intragastric exposure in a food allergy model in mice

机译:小鼠食品过敏模型中胃内暴露后Cry1ab蛋白免疫原性,过敏性和佐剂特性的研究

获取原文
           

摘要

Background In genetically modified (GM) crops there is a risk that the inserted genes may introduce new allergens and/or adjuvants into the food and feed chain. The MON810 maize, expressing the insecticidal Cry1Ab toxin, is grown in many countries worldwide. In animal models, intranasal and intraperitoneal immunisations with the purified Cry1Ab proteins have induced immune responses, and feeding trials with Cry1Ab-containing feed have revealed some altered immune responses. Previous investigations have primarily measured antibody responses to the protein, while investigations of clinical food allergy symptoms, or allergy promotion (adjuvant effect) associated with the Cry1Ab protein are largely missing. We aimed to investigate immunogenic, allergenic and adjuvant properties of purified Cry1Ab toxin (trypCry1Ab, i.e., trypsin activated Cry1Ab) in a mouse model of food allergy. Method Female C3H/HeJ mice were immunized by intragastric gavage of 10?μg purified, trypsin activated Cry1Ab toxin (trypCry1Ab) alone or together with the food allergen lupin. Cholera toxin was added as a positive control for adjuvant effect to break oral tolerance. Clinical symptoms (anaphylaxis) as well as humoral and cellular responses were assessed. Results In contrast to results from previous airway investigations, we observed no indication of immunogenic properties of trypCry1Ab protein after repeated intragastric exposures to one dose, with or without CT as adjuvant. Moreover, the results indicated that trypCry1Ab given by the intragastric route was not able to promote allergic responses or anaphylactic reactions against the co-administered allergen lupin at the given dose. Conclusion The study suggests no immunogenic, allergenic or adjuvant capacity of the given dose of trypCry1Ab protein after intragastric exposure of prime aged mice.
机译:背景技术在遗传修饰的(GM)作物中,存在插入的基因可能将新的过敏原和/或佐剂引入食物和饲料链中存在风险。在全世界的许多国家,表达杀虫Cry1ab毒素的MON810玉米。在动物模型中,含有纯化的Cry1ab蛋白的鼻内和腹膜内免疫诱导免疫应答,并用含Cry1ab的饲料喂养试验揭示了一些改变的免疫应答。先前的研究主要测量对蛋白质的抗体反应,同时对与Cry1ab蛋白相关的临床食物过敏症状或过敏促进(佐剂效应)的调查在很大程度上缺失。我们的旨在在食物过敏的小鼠模型中探讨纯化的Cry1ab毒素(Trypcry1ab,I.,I.,Trypsin活化Cry1ab)的免疫原性,过敏性和佐剂性能。通过10βμg纯化的胰蛋白酶激活的Cry1ab毒素(Trypcry1ab)或与食品过敏原羽扇豆一起免疫方法C3H / HEJ小鼠。加入霍乱毒素作为辅助效应的阳性对照,以破坏口服耐受性。评估临床症状(过敏反应)以及体液和细胞反应。结果与先前的气道调查结果相比,我们观察到在重复胃内暴露至一剂后,无论是否有或没有CT作为佐剂,术后没有观察到胰蛋白酶1ab蛋白的免疫原性特性。此外,结果表明,胃内途径给出的TRYPCRY1ab不能在给定剂量的对施用过敏反应或过敏反应的过敏反应或过敏反应。结论该研究表明,在血液老龄化小鼠的胃内暴露后,对给定剂量的胰蛋白酶蛋白的免疫原性,过敏性或佐剂能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号